PT  - JOURNAL ARTICLE
AU  - Bassett, Bruce A.
TI  - Strict Lower Bound on the COVID-19 Fatality Rate in Overwhelmed Healthcare Systems
AID  - 10.1101/2020.04.22.20076026
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.22.20076026
4099  - http://medrxiv.org/content/early/2020/04/27/2020.04.22.20076026.short
4100  - http://medrxiv.org/content/early/2020/04/27/2020.04.22.20076026.full
AB  - The Infection Fatality Rate (IFR) for COVID-19 is a poorly known, yet crucial, aspect of the disease. Counting only current deaths in a region and assuming everyone in that region is infected provides an absolute lower bound on the IFR. Using this estimator for New York City, Lombardy and Madrid yields strong bounds on the average IFR in overwhelmed health systems. Their combined 35, 152 deaths implies an IFR ≥ 0.14% averaged over 25.1 million people. This is the best-case scenario and conclusively demonstrates that COVID-19 is more deadly than influenza. The actual value of the average COVID-19 IFR is likely to be higher than this bound.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding has been received to support this research. The authors have not received payment of services from any third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are publicly available from third-party sources.